<DOC>
	<DOCNO>NCT01666041</DOCNO>
	<brief_summary>The investigator hypothesize fenofibrate/omega improve insulin resistance compare fenofibrate</brief_summary>
	<brief_title>Vascular Metabolic Effects Fenofibrate/Omega v Fenofibrate</brief_title>
	<detailed_description />
	<mesh_term>Hypertriglyceridemia</mesh_term>
	<mesh_term>Fenofibrate</mesh_term>
	<criteria>hypertriglyceridemia moderate severe hypertension , uncontrolled diabetes ( HbA1c &gt; 9 % ) , nephrotic syndrome , hypothyroidism , coronary artery disease , peripheral vascular disease</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>insulin resistance</keyword>
</DOC>